Gallbladder removal surgeries jumped 15% over the past year, and surgeons suspect weight-loss injections may be driving the increase. The drugs, which include semaglutide and tirzepatide, have exploded in popularity for treating obesity and diabetes. Rapid weight loss can trigger gallstone formation, a known medical risk. The sudden spike in removals has prompted calls from the surgical community for dedicated research into the connection. Health authorities have not yet confirmed a causal link, but the timing coincides with the widespread adoption of these injectable medications. Surgeons are urging studies to establish whether the correlation reflects genuine causation or reflects other factors. The finding raises questions about the broader health implications of rapid weight loss drugs as they scale to millions of users globally.